会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • METHOD OF TREATING GLAUCOMA
    • 治疗玻璃体的方法
    • WO2008124009A2
    • 2008-10-16
    • PCT/US2008004299
    • 2008-04-02
    • CLEVELAND CLINIC FOUNDATIONKRUEGER RONALD RDUPPS WILLIAM JTROKEL STEVENTHORNTON IVEY
    • KRUEGER RONALD RDUPPS WILLIAM JTROKEL STEVENTHORNTON IVEY
    • A61P27/06A61K31/11A61K31/525A61K31/70A61K33/00A61K45/00
    • A61K31/11A61K31/525A61K31/70A61K45/06A61K2300/00
    • Provided herein are methods of protecting all or a portion of the optic nerve fiber layer within the optic nerve/lamina cribrosa (ONLC) complex in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of an agent that results in crosslinking of collagen in the indiviudal's peripapillary sclera, thereby stiffening the individual's peripapillary sclera and protecting all or a portion of the optic nerve fiber layer within the ONLC of the individual. In a particular embodiment, the invention is directed to methods of treating glaucoma in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of an agent that results in crosslinking of collagen in the indiviudal's peripapillary sclera, thereby stiffening the individual's peripapillary sclera and treating the glaucoma in the individual. In yet another embodiment, the invention is directed to methods of treating glaucomatous optic neuropathy in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of an agent that results in crosslinking of collagen in the indiviudal's peripapillary sclera, thereby stiffening the individual's peripapillary sclera and treating the glaucomatous optic neuropathy in the individual. The method can further comprise administering to the individual a therapeutically effective amount of an agent that results in crosslinking of collagen in the indiviudal's lamina cribrosa (LC).
    • 本文提供的方法是在有需要的个体中保护视神经/椎板(ONLC)复合物内视神经纤维层的全部或一部分的方法,包括向个体施用治疗有效量的导致交联的试剂 的胶原蛋白,从而使个体的周围巩膜硬化,并保护个体的ONLC内的全部或部分视神经纤维层。 在一个具体实施方案中,本发明涉及在有需要的个体中治疗青光眼的方法,其包括向所述个体施用治疗有效量的导致胶原蛋白在角膜周围巩膜中交联的药剂,从而加强个体的周围毛细血管 巩膜并治疗个体青光眼。 在另一个实施方案中,本发明涉及在有需要的个体中治疗青光眼性视神经病变的方法,其包括向所述个体施用治疗有效量的导致胶原蛋白在斑块周围巩膜中的交联的试剂,从而使 个体的周围巩膜巩膜和治疗个体的青光眼性视神经病变。 该方法可以进一步包括向个体施用治疗有效量的导致胶原蛋白交联的药剂(LC)。